Detection of germline deletions using real-time quantitative polymerase chain reaction in Japanese patients with von Hippel-Lindau disease

Cancer Science

Volumn 97, Issue 5, 2006, Pages 400-405

  Hattori, Keiko ^a   Teranishi, Jun Ichi ^a   Stolle, Catherine ^b   Yoshida, Minoru ^a   Kondo, Kei Ichi ^a   Kishida, Takeshi ^a   Kanno, Hiroshi ^a   Baba, Masaya ^a   Kubota, Yoshinobu ^a   Yao, Masahiro ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VON HIPPEL LINDAU PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; EXON; FAMILY; GENE DELETION; GENE MUTATION; HETEROZYGOTE DETECTION; HUMAN; JAPAN; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VON HIPPEL LINDAU DISEASE;

3' UNTRANSLATED REGIONS; BLOTTING, SOUTHERN; COHORT STUDIES; DNA; EXONS; FAMILY; FLUORESCENT DYES; GENETIC SCREENING; GERM-LINE MUTATION; HIPPEL-LINDAU DISEASE; HUMANS; JAPAN; MODELS, GENETIC; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 33645552987     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00193.x     Document Type: Article

References (25)

1. Lonser RR, Glenn GM, Walther M et al. Von Hippel-Lindau disease. Lancet 2003; 361: 2059-67.
2. Maher ER. Von Hippel-Lindau disease. Curr Mol Med 2004; 4: 833-42.
3. Latif F, Tory K, Gnarra J et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260: 1317-20.
4. Zbar B, Kishida T, Chen F et al. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 1996; 8: 348-57.
5. Zbar B, Kaelin W, Maher E, Richard S. Third International Meeting on von Hippel-Lindau disease. Cancer Res 1999; 59: 2251-3.
6. Decker HJ, Neuhaus C, Jauch A et al. Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH. Hum Genet 1996; 97: 770-6.
7. Hes F, Zewald R, Peeters T et al. Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene. Hum Genet 2000; 106: 425-31.
8. Yao M, Latif F, Kuzmin I et al. Von Hippel-Lindau disease: identification of deletion mutations by pulsed-field gel electrophoresis. Hum Genet 1993; 92: 605-14.
9. Richards FM, Phipps ME, Latif F et al. Mapping the Von Hippel-Lindau disease tumour suppressor gene: Identification of germline deletions by pulsed field gel electrophoresis. Hum Mol Genet 1993; 2: 879-82.
10. Stolle C, Glenn G, Zbar B et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 1998; 12: 417-23.
11. Cybulski C, Krzystolik K, Maher ER et al. Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene. Hum Genet 1999; 105: 333-6.
12. Pack SD, Zbar B, Pak E et al. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. Cancer Res 1999; 59: 5560-4.
13. Fink L, Seeger W, Ermert L et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 1998; 4: 1329-33.
14. Bieche I, Olivi M, Champeme MH, Vidaud D, Lidereau R, Vidaud M. Novel approach to quantitative polymerase chain reaction using real-time detection: Application to the detection of gene amplification in breast cancer. Int J Cancer 1999; 78: 661-6.
15. Sieber OM, Lamlum H, Crabtree MD et al. Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or 'multiple' colorectal adenomas. Proc Natl Acad Sci USA 2002; 99: 2954-8.
16. Kondo K et al. Clinical Research Group for VHL in Japan: Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Hum Mol Genet 1995; 4: 2233-7.
17. Yoshida M, Ashida S, Kondo K et al. Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: An extended study of 77 families. Jpn J Cancer Res 2000; 91: 204-12.
18. Zatyka M, Morrissey C, Kuzmin I et al. Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter. J Med Genet 2002; 39: 463-72.
19. Hoebeeck J, van der Luijt R, Poppe B et al. Rapid detection of VHL exon deletions using real-time quantitative PCR. Laboratory Invest 2005; 85: 24-33.
20. Hes FJ, Hoppener JW, Lips CJM. Pheochromocytoma in von Hippel-Lindau disease. J Clin Endocrinol Metab 2003; 88: 969-74.
21. Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol 2004; 22: 4991-5004.
22. Murgia A, Martella M, Vinanzi C, Polli R, Perilongo G, Opocher G. Somatic mosaicism in von Hippel-Lindau Disease. Hum Mutat 2000; 15: 114.
23. Sgambati MT, Stolle C, Choyke PL et al. Mosaicism in von Hippel-Lindau disease: Lessons from kindreds with germline mutations identified in offspring with mosaic parents. Am J Hum Genet 2000; 66: 84-91.
24. Neumann HP, Bausch B, McWhinney SR et al. Germ-line mutations in nonsyndromic pheochromocytoma. New Eng J Med 2002; 346: 1459-66.
25. Maher ER, Eng C. The pressure rises: Update on the genetics of phaeochromocytoma. Hum Mol Genet 2002; 11: 2347-54.